All Stories

  1. Immunotherapy for the Treatment of Hepatocellular Carcinoma
  2. The Role of microRNA in Hepatic Ischemia/Reperfusion Injury
  3. Challenges in the Management of Hepatoblastoma
  4. Rple of microRNA in the diagnosis and therapy of liver metastases from colorectal cancer
  5. The Developing Role of Sorafenib in the Management of Hepatocellular Carcinoma
  6. Role of MicroRNA in the Diagnosis and Therapy of Hepatocellular Carcinoma: A New Frontier
  7. The evolving role of transarterial chemoembolization in the management of hepatocellular carcinoma
  8. Current and Future Challenges in the Surgical Treatment of Hepatocellular Carcinoma: A Review
  9. The IXth Biennial Meeting of the Mediterranean Society of Coloproctology, May 22–23, 2014
  10. Management of Colorectal Hepatic Metastases: Time for Targeted Patient Care
  11. Ischemia reperfusion injury and the immune system
  12. Surgically engineering the future
  13. Lung ischemia-reperfusion injury: when NO (nitric oxide) does not always mean no
  14. The long and winding road to immune tolerance
  15. Commentary on: Lipid peroxidation in machine perfusion of older donor kidneys
  16. Genomics and transplantation: a brave new world is (almost) here
  17. Commentary on: Age-related differences in hepatic ischemia/reperfusion: gene activation, liver injury, and protective effect of melatonin
  18. Commentary on “Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation”
  19. Commentary on “Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning”
  20. Role of extended lymphadenectomy in the treatment of pancreatic head adenocarcinoma: review and meta-analysis
  21. Commentary on “Liver transplantation with donation-after-cardiac-death donors: A comprehensive update”
  22. Hepatic Ischemia and Reperfusion Injury and Trauma: Current Concepts
  23. Hepatic Ischemia and Reperfusion Injury and Trauma: Current Concepts
  24. Commentary on “Prophylaxis against HBV recurrence after liver transplantation for HBV-related endstage liver diseases with severe hypersplenism and splenomegaly: Role of splenectomy”
  25. The Role of Surgery in the Treatment of Hepatocellular Carcinoma
  26. Intravenous leiomyomatosis with involvement of the right heart
  27. Blockade of chloride ion transport enhances the cytocidal effect of hypotonic solution in gastric cancer cells
  28. Commentary on “Interaction between Kupffer cells and platelets in the early period of hepatic ischemia-reperfusion injury”
  29. Laparoscopic Living Donor Nephrectomy: Is it OK to Be Right?
  30. Laparoscopic Living Donor Nephrectomy: Is There a Difference Between Using a Left or a Right Kidney?
  31. Cyclosporin-A Does Not Prevent Cold Ischemia/Reperfusion Injury of Rat Livers
  32. Surgical treatment for large hepatocellular carcinoma: does size matter?
  33. Rectal Cancer - Staging and Surgical Approach
  34. The Role of Liver Transplantation in theTreatment of Alcoholic Liver Disease
  35. Management of Rectal Cancer and Liver Metastatic Disease: Which Comes First?
  36. Abdominoperineal Resection for Rectal Cancer: Is the Pelvic Drain Externalization Site an Independent Risk Factor for Perineal Wound Healing?
  37. The Treatment of Metastatic Liver Disease of Colorectal Origin
  38. Commentary on “Preemptive Therapy with Steroids but not Macrolides Improves Gas Exchange in Caustic-Injured Donor Lungs”
  39. Management of concurrent colorectal cancer and vascular disease in the endovascular era
  40. Laparoscopic Appendectomy
  41. Right Hepatic Lobectomy
  42. Left Hepatic Lobectomy
  43. Hepatic Wedge Resection
  44. Plication of Perforated Peptic Ulcer
  45. Surgical management of a large hepatocellular carcinoma in an octogenarian patient
  46. High mortality in orthotopic liver transplant recipients who require hemodialysis
  47. Surgical treatment of hepatic metastases from colorectal cancer
  48. Successful, combined long-term treatment of cerebral aspergillosis in a liver transplant patient
  49. Long-term experience with liver transplantation for hepatocellular carcinoma
  50. Lessons Learned in the First Decade of a Laparoscopic Living Donor Nephrectomy Program
  51. The Evolution of the Role of Liver Transplantation in Treating Alcoholic Cirrhosis in Greece
  52. Impact of Double-J Ureteric Stent in Kidney Transplantation: Single-Center Experience
  53. Common Iliac Artery Lying Posterior to Psoas Major Identified During Kidney Transplantation
  54. The Cumulative Effects of Cold Ischemic Time and Older Donor Age on Liver Graft Survival
  55. Stratifying Risk of Biliary Complications in Adult Living Donor Liver Transplantation by Magnetic Resonance Cholangiography
  56. Pharmacokinetics of Mycophenolic Acid in Live Donor Liver Transplant Patients vs Deceased Donor Liver Transplant Patients
  57. Long-term Outcome of a Cuffed Expanded PTFE Graft for Hemodialysis Vascular Access
  58. Minimizing Morbidity of Organ Donation: Analysis of Factors for Perioperative Complications After Living-Donor Nephrectomy in the United States
  59. Pharmacokinetics of Tacrolimus in Living Donor Liver Transplant and Deceased Donor Liver Transplant Recipients
  60. Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction
  61. Living-Donor Liver Transplantation in the United States: Identifying Donors at Risk for Perioperative Complications
  62. Disparate patient survival among UNOS regions after liver transplantation for hepatocellular carcinoma
  63. [131] PHARMACOKINETICS OF TACROLIMUS AND MYCOPHENOLATE MOFETIL (MMF) IN LIVE DONOR AND DECEASED DONOR LIVER TRANSPLANT RECIPIENTS
  64. Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil
  65. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis
  66. Pediatric Liver and Kidney Transplantation With Allografts From DCD Donors: A Review of UNOS Data
  67. Hydrodynamic Plasmid DNA Gene Therapy Model in Liver Transplantation
  68. A single center, retrospective study on a cuffed expanded polutetrafluoroethylene graft for hemodialysis vascular access
  69. Right Hepatic Lobectomy
  70. Left Hepatic Lobectomy
  71. Laparoscopic Appendectomy
  72. Hepatic Wedge Resection
  73. Plication of Perforated Peptic Ulcer
  74. Laparoscopic surgery for the prevention, palliation, and cure of gastrointestinal malignancies
  75. Role of NF-κB on liver cold ischemia-reperfusion injury
  76. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury12
  77. NF-κB in transplantation: friend or foe?
  78. Protective Role of the L-Arginine-Nitric Oxide Synthase Pathway on Preservation Injury after Rat Liver Transplantation
  79. Former Prisoners' Views on Mandatory HIV Testing During Incarceration